ORYX Translational Medicine
Developing cancer treatments
- B2B
About ORYX Translational Medicine
A German biotech company with a unique approach to combat cancer, focusing on three academic projects with proven clinical potential for final development by pharma
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Vaterstetten, Bavaria, Germany
- Founded
- 2007
- Revenue
- $1.7M – $13.6MTamtam estimate
- Website
- oryx-medicine.com
ORYX Translational Medicine at a glance
ORYX Translational Medicine is a B2B company in the Biotechnology Research industry, headquartered in Vaterstetten, Bavaria, Germany.
ORYX Translational Medicine was founded in 2007.
ORYX Translational Medicine has 1–10 employees.
ORYX Translational Medicine's revenue is $1.7M – $13.6M (Tamtam estimate).
Frequently asked questions about ORYX Translational Medicine
What is ORYX Translational Medicine's revenue?
Tamtam estimates ORYX Translational Medicine's annual revenue at $1.7M – $13.6M.
How many employees does ORYX Translational Medicine have?
ORYX Translational Medicine has 1–10 employees.
Where is ORYX Translational Medicine headquartered?
ORYX Translational Medicine is headquartered in Vaterstetten, Bavaria, Germany.
Selling to companies like ORYX Translational Medicine?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies